These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 24238946)
1. Immunochemical faecal occult blood tests for colorectal cancer screening: no time to lose. Lepage C Dig Liver Dis; 2014 Jan; 46(1):30-1. PubMed ID: 24238946 [No Abstract] [Full Text] [Related]
2. The impact of immunochemical faecal occult blood testing on colorectal cancer incidence. Ventura L; Mantellini P; Grazzini G; Castiglione G; Buzzoni C; Rubeca T; Sacchettini C; Paci E; Zappa M Dig Liver Dis; 2014 Jan; 46(1):82-6. PubMed ID: 24011791 [TBL] [Abstract][Full Text] [Related]
3. Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis. Vart G; Banzi R; Minozzi S Prev Med; 2012 Aug; 55(2):87-92. PubMed ID: 22634386 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of colorectal cancer with false negative result on immunochemical faecal occult blood test. Nakama H; Kamijo N; Fujimori K; Horiuchi A; Fattah AS; Zhang B J Med Screen; 1996; 3(3):115-8. PubMed ID: 8946304 [TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of immunochemical tests for colorectal cancer screening. Lejeune C; Le Gleut K; Cottet V; Galimard C; Durand G; Dancourt V; Faivre J Dig Liver Dis; 2014 Jan; 46(1):76-81. PubMed ID: 24012177 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of immunochemical faecal occult blood tests according to number of samples and positivity threshold. Guittet L; Launoy G J Med Screen; 2008; 15(1):48-9. PubMed ID: 18416958 [No Abstract] [Full Text] [Related]
7. Faecal immunochemical tests in the COVID-19 pandemic; safety-netting of patients with symptoms and low faecal haemoglobin concentration - can a repeat test be used? Benton SC; Fraser CG Ann Clin Biochem; 2021 May; 58(3):163-165. PubMed ID: 33016079 [No Abstract] [Full Text] [Related]
8. Diagnostic accuracy of immunochemical faecal occult blood test for gastric cancer. Nakama H; Kamijo N; Fujimori K; Fattah AS; Zhang B J Med Screen; 1996; 3(3):113-4. PubMed ID: 8946303 [TBL] [Abstract][Full Text] [Related]
9. Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test. Birkenfeld S; Belfer RG; Chared M; Vilkin A; Barchana M; Lifshitz I; Fruchter D; Aronski D; Balicer R; Niv Y; Levi Z J Med Screen; 2011; 18(3):135-41. PubMed ID: 22045822 [TBL] [Abstract][Full Text] [Related]
10. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test. Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942 [TBL] [Abstract][Full Text] [Related]
11. Immunochemical fecal occult blood tests for colorectal cancer screening. Allison JE Am J Med; 2004 Apr; 116(7):498; author reply 498-9. PubMed ID: 15047043 [No Abstract] [Full Text] [Related]
12. Well adjusted qualitative immunochemical faecal occult blood tests could be a promising alternative for inexpensive, high-quality colorectal cancer screening. Tao S; Brenner H Eur J Cancer Prev; 2013 Jul; 22(4):305-10. PubMed ID: 23702679 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. Burch JA; Soares-Weiser K; St John DJ; Duffy S; Smith S; Kleijnen J; Westwood M J Med Screen; 2007; 14(3):132-7. PubMed ID: 17925085 [TBL] [Abstract][Full Text] [Related]
14. Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme. Faivre J; Dancourt V; Manfredi S; Denis B; Durand G; Gendre I; Bidan JM; Jard C; Levillain R; Jung S; Viguier J; Dorval E Dig Liver Dis; 2012 Aug; 44(8):700-4. PubMed ID: 22542582 [TBL] [Abstract][Full Text] [Related]
15. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme. Kelley L; Swan N; Hughes DJ Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062 [TBL] [Abstract][Full Text] [Related]
16. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies. Van Roosbroeck S; Hoeck S; Van Hal G Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885 [TBL] [Abstract][Full Text] [Related]
17. A combination of clinical risk stratification and fecal immunochemical test is useful for identifying persons with high priority of early colonoscopy. Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI Dig Liver Dis; 2018 Mar; 50(3):254-259. PubMed ID: 29198569 [TBL] [Abstract][Full Text] [Related]
18. A case-control study to evaluate efficacy of screening for faecal occult blood. Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161 [TBL] [Abstract][Full Text] [Related]
19. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer? Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281 [TBL] [Abstract][Full Text] [Related]
20. Feasibility of immunochemical faecal occult blood testing for colorectal cancer screening in Bulgaria. Tsvetanova Dimova R; Dimitrova Dimitrova D; Angelova Levterova B; Stoyanov Dimov R; Atanasova Semerdjieva M; Frantova Tarnovska M; Gencheva Stoyanova R J BUON; 2015; 20(2):413-20. PubMed ID: 26011330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]